Product Information
LEVETIRACETAM 1,000 MG TABLET is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $0.1597 per EA under NDC 72205009760. Its NADAC has been published 174 times since Jun 7, 2023.
FDA first approved this application on Oct 7, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1000 mg/1
Manufacturer
Novadoz Pharmaceuticals LLCNDC
72205009760
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LEVETIRACETAMApproval Type
Generic (ANDA)
FDA Application
ANDA214815FDA Approved
10/7/2022
TE Code
AB
On Market Since
10/7/2022
Pharmacological Classes
Price Statistics
The NADAC for LEVETIRACETAM 1,000 MG TABLET has been published 174 times since Jun 7, 2023, and over the history we have for it it has declined 20.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1597 per EA |
|---|---|
| All-time high | $0.2036 (Aug 16, 2023) |
| All-time low | $0.1447 (Nov 20, 2024) |
| 52-week high | $0.1663 |
| 52-week low | $0.1552 |
| Median price | $0.1643 |
| Average price | $0.1725 |
| Largest weekly change | +17.3% (Aug 21, 2024) |
| Weeks tracked | 174 |
| Tracking since | Jun 7, 2023 |
Generic Alternatives
The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Novadoz Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levetiracetam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVETIRACETAM 1,000 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 1,000 MG TABLET, manufactured by Novadoz Pharmaceuticals LLC, is $0.1597 per EA (NDC 72205009760), effective Sep 30, 2026.
How has the price of LEVETIRACETAM 1,000 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVETIRACETAM 1,000 MG TABLET has declined 20.3%. It has been tracked across 174 weekly CMS publications since Jun 7, 2023.
What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 1,000 MG TABLET?
Since Jun 7, 2023, the NADAC for LEVETIRACETAM 1,000 MG TABLET has ranged from a low of $0.1447 (Nov 20, 2024) to a high of $0.2036 (Aug 16, 2023), with a median of $0.1643 per EA.
Are there cheaper alternatives to LEVETIRACETAM 1,000 MG TABLET?
14 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LEVETIRACETAM 1,000 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LEVETIRACETAM 1,000 MG TABLET?
LEVETIRACETAM 1,000 MG TABLET (NDC 72205009760) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.